Patent Coordinators. Each Party will appoint a patent coordinator reasonably acceptable to the other Party (each, a “Patent Coordinator”) to serve as such Party’s primary liaison with the other Party on matters relating to the Prosecution and Maintenance and enforcement of Licensed Patents and Joint Program Patents. The Patent Coordinators will meet in person or by means of telephone or video conference at least once each Calendar Quarter during the Agreement Term. Each Party may replace its Patent Coordinator at any time by providing notice in writing to the other Party. The initial Patent Coordinators will be: For Vertex: ▇▇▇▇▇ ▇▇▇▇▇ For CRISPR: ▇▇▇▇▇ ▇▇▇▇▇-▇▇▇▇
Appears in 2 contracts
Sources: Strategic Collaboration, Option and License Agreement (CRISPR Therapeutics AG), Strategic Collaboration, Option and License Agreement (CRISPR Therapeutics AG)
Patent Coordinators. Each Party will appoint a patent coordinator (who can be either an employee or an external patent counsel) reasonably acceptable to the other Party (each, a “Patent Coordinator”) to serve as such Party’s primary liaison with the other Party on matters relating to the Prosecution and Maintenance and enforcement of Licensed CRISPR Arising Patents, Sirius Arising Patents and Joint Program PatentsPatents pursuant to Section 2.1.3(c). The Patent Coordinators will meet in person or by means of telephone or video conference at least once [***] each Calendar Quarter during the Agreement Term. Each Party may replace its Patent Coordinator at any time by providing notice in writing to the other Party. The initial Patent Coordinators will be: For VertexSirius: ▇▇▇▇▇ ▇▇▇▇▇ [***] For CRISPR: ▇▇▇▇▇ ▇▇▇▇▇-▇▇▇▇[***]
Appears in 1 contract
Sources: Collaboration, Option and License Agreement (CRISPR Therapeutics AG)
Patent Coordinators. Each Party will appoint a patent coordinator reasonably acceptable to the other Party (each, a “Patent Coordinator”) to serve as such Party’s primary liaison with the other Party on matters relating to the Prosecution and Maintenance and enforcement of Licensed Patents and Joint Program Patents. The Patent Coordinators (or their designees) will meet in person or by means of telephone or video conference at least once each Calendar Quarter during the Agreement Term. Each Party may replace its Patent Coordinator at any time by providing notice in writing to the other Party. The initial Patent Coordinators will be: For Vertex: ▇▇▇▇▇ ▇▇▇▇▇ [***] For CRISPR: ▇▇▇▇▇ ▇▇▇▇▇-▇▇▇▇[***]
Appears in 1 contract
Sources: Strategic Collaboration and License Agreement (CRISPR Therapeutics AG)
Patent Coordinators. Each Party will appoint a patent coordinator reasonably acceptable to the other Party (each, a “Patent Coordinator”) to serve as such Party’s 's primary liaison with the other Party on matters relating to the Prosecution and Maintenance and enforcement of Licensed Patents and Joint Program Patents. The Patent Coordinators will meet in person or by means of telephone or video conference at least once each Calendar Quarter during the Agreement Term. Each Party may replace its Patent Coordinator at any time by providing notice in writing to the other Party. The initial Patent Coordinators will be: For VertexViaCyte: ▇▇▇▇▇ ▇▇▇▇▇ , Ph.D. For CRISPR: ▇▇▇▇▇▇ ▇▇▇▇▇-▇▇▇▇
Appears in 1 contract
Sources: Research Collaboration Agreement (CRISPR Therapeutics AG)
Patent Coordinators. Each Party will appoint a patent coordinator reasonably acceptable to the other Party Parties (each, a “Patent Coordinator”) to serve as such Party’s primary liaison with the other Party Parties on matters relating to the Prosecution and Maintenance and enforcement of Licensed the Company Program Patents and Joint Program Patents. The Patent Coordinators will meet in person or by means of telephone or video conference at least once each Calendar Quarter during the Agreement Term. Each Party will provide the other Parties written notice of its Patent Coordinator and may replace its Patent Coordinator at any time by providing notice in writing to the other Party. The initial Patent Coordinators will be: For Vertex: ▇▇▇▇▇ ▇▇▇▇▇ For CRISPR: ▇▇▇▇▇ ▇▇▇▇▇-▇▇▇▇Parties.
Appears in 1 contract
Patent Coordinators. Each Party will appoint a patent coordinator reasonably acceptable to the other Party (each, a “Patent Coordinator”) to serve as such Party’s 's primary liaison with the other Party on matters relating to the Prosecution and Maintenance and enforcement of Licensed Patents and Joint Program Patents. The Patent Coordinators will meet in person or by means of telephone or video conference at least once each Calendar Quarter during the Agreement Term. Each Party may replace its Patent Coordinator at any time by providing notice in writing to the other Party. The initial Patent Coordinators will be: For Vertex: ▇▇▇▇▇ ▇▇▇▇▇ For CRISPR: ▇▇▇▇▇ ▇▇▇▇▇-▇▇▇▇
Appears in 1 contract
Sources: Strategic Collaboration, Option and License Agreement (Vertex Pharmaceuticals Inc / Ma)